ABEV vs. KDP, STZ, BF.B, DEO, KMB, KHC, KVUE, GIS, CTVA, and ADM
Should you be buying Ambev stock or one of its competitors? The main competitors of Ambev include Keurig Dr Pepper (KDP), Constellation Brands (STZ), Brown-Forman (BF.B), Diageo (DEO), Kimberly-Clark (KMB), Kraft Heinz (KHC), Kenvue (KVUE), General Mills (GIS), Corteva (CTVA), and Archer-Daniels-Midland (ADM). These companies are all part of the "consumer staples" sector.
Ambev vs.
Ambev (NYSE:ABEV) and Keurig Dr Pepper (NASDAQ:KDP) are both large-cap consumer staples companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, community ranking, earnings and profitability.
8.8% of Ambev shares are owned by institutional investors. Comparatively, 52.3% of Keurig Dr Pepper shares are owned by institutional investors. 0.8% of Keurig Dr Pepper shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
In the previous week, Ambev and Ambev both had 5 articles in the media. Ambev's average media sentiment score of 1.33 beat Keurig Dr Pepper's score of 0.83 indicating that Ambev is being referred to more favorably in the media.
Ambev received 352 more outperform votes than Keurig Dr Pepper when rated by MarketBeat users. Likewise, 60.60% of users gave Ambev an outperform vote while only 26.19% of users gave Keurig Dr Pepper an outperform vote.
Ambev has a net margin of 18.00% compared to Keurig Dr Pepper's net margin of 9.20%. Ambev's return on equity of 17.44% beat Keurig Dr Pepper's return on equity.
Ambev has higher revenue and earnings than Keurig Dr Pepper. Ambev is trading at a lower price-to-earnings ratio than Keurig Dr Pepper, indicating that it is currently the more affordable of the two stocks.
Ambev has a beta of 1.08, indicating that its share price is 8% more volatile than the S&P 500. Comparatively, Keurig Dr Pepper has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.
Ambev pays an annual dividend of $0.12 per share and has a dividend yield of 4.0%. Keurig Dr Pepper pays an annual dividend of $0.80 per share and has a dividend yield of 2.6%. Ambev pays out 66.7% of its earnings in the form of a dividend. Keurig Dr Pepper pays out 86.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ambev is clearly the better dividend stock, given its higher yield and lower payout ratio.
Ambev currently has a consensus target price of $3.74, indicating a potential upside of 25.29%. Keurig Dr Pepper has a consensus target price of $37.56, indicating a potential upside of 19.95%. Given Ambev's stronger consensus rating and higher probable upside, equities research analysts clearly believe Ambev is more favorable than Keurig Dr Pepper.
Summary
Ambev beats Keurig Dr Pepper on 13 of the 19 factors compared between the two stocks.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding ABEV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools